it crosses the blood-brain barrier and has been found in the research to potentially benefit those with various neurodegenerative diseases
It is a safe and efficacious alternative or adjunct to TRT for men who would like to preserve fertility during treating for Low T, or hypogonadism
Scenario 1: Private Insurance with Manufacturer Program Profile: 45-year-old with employer-provided insurance (Sun Life), BMI 35, type 2 diabetes Coverage: Insurance approves after prior authorization, covers 70% after $500 deductible Calculation: Annual retail cost: $21,000 Deductible: $500 Insurance pays 70% of remaining $20,500 = $14,350 Patient owes: $6,650 Manufacturer program saves: $2,800 Final patient cost: $3,850 annually ($320/month) Verdict: Most affordable scenario
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Oral semaglutide doses included 0.05 mg/kg, 0.12 mg/kg, 0.23 mg/kg, and 0.7 mg/kg, which were equivalent to three, seven, 14, and 42 mg human doses, respectively